phenylalanine and beta-funaltrexamine

phenylalanine has been researched along with beta-funaltrexamine in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fournié-Zaluski, MC; Fuentes, JA; Hernando, F; Roques, BP; Ruiz-Gayo, M	1
Besson, JM; Catheline, G; Fournié-Zaluski, MC; Honoré, P; Le Guen, S; Roques, BP	1

Other Studies

2 other study(ies) available for phenylalanine and beta-funaltrexamine

Article	Year
Antidepressant-like effects of CCK(B) receptor antagonists: involvement of the opioid system. European journal of pharmacology, 1996, Dec-30, Volume: 318, Issue:2-3 Topics: Animals; Antidepressive Agents; Benzodiazepinones; Devazepide; Disulfides; Endorphins; Male; Mice; Naloxone; Naltrexone; Phenylalanine; Phenylurea Compounds; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Sincalide	1996
The effects of RB101, a mixed inhibitor of enkephalin-catabolizing enzymes, on carrageenin-induced spinal c-Fos expression are completely blocked by beta-funaltrexamine, a selective mu-opioid receptor antagonist. Brain research, 1999, Jul-10, Volume: 834, Issue:1-2 Topics: Animals; Carrageenan; Disulfides; Enzyme Inhibitors; Male; Naltrexone; Narcotic Antagonists; Neprilysin; Phenylalanine; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Spinal Cord	1999

Article

Year

Antidepressant-like effects of CCK(B) receptor antagonists: involvement of the opioid system.

European journal of pharmacology, 1996, Dec-30, Volume: 318, Issue:2-3

Topics: Animals; Antidepressive Agents; Benzodiazepinones; Devazepide; Disulfides; Endorphins; Male; Mice; Naloxone; Naltrexone; Phenylalanine; Phenylurea Compounds; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Sincalide

1996

The effects of RB101, a mixed inhibitor of enkephalin-catabolizing enzymes, on carrageenin-induced spinal c-Fos expression are completely blocked by beta-funaltrexamine, a selective mu-opioid receptor antagonist.

Brain research, 1999, Jul-10, Volume: 834, Issue:1-2

Topics: Animals; Carrageenan; Disulfides; Enzyme Inhibitors; Male; Naltrexone; Narcotic Antagonists; Neprilysin; Phenylalanine; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Spinal Cord

1999